Eczema trials recruiting in North Dakota

All Eczema trials nationally

Cities in North Dakota

Recruiting trials in North Dakota

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Dakota: Fargo
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · North Dakota: Fargo
• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
  NCT06982352 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · North Dakota: Fargo
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · North Dakota: Fargo